Level C· Early human research exploring benefitsCohort StudyPubMed

Adipose Insulin Resistance in Normal-Weight Women With Polycystic Ovary Syndrome.

Dumesic DA., Phan JD., Leung KL., Grogan TR., Ding X., Li X.

Cohort Study on Type 2 Diabetes, published in J Clin Endocrinol Metab (2019) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Cohort Study
Journal
J Clin Endocrinol Metab (2019)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
30649347
PMCID
PMC6482023
DOI
10.1210/jc.2018-02086
Citations
67

Abstract (original English)

Normal-weight women with polycystic ovary syndrome (PCOS) may have adipose tissue insulin resistance (adipose-IR). To examine whether adipose-IR and subcutaneous (SC) abdominal adipose stem cell (ASC) gene expression are altered in normal-weight women with PCOS and correlated with hyperandrogenemia and/or whole-body IR. Prospective cohort study. Academic medical center. Ten normal-weight women with PCOS and 18 control subjects matched for age and body mass index. Women underwent circulating hormone and metabolic measurements, IV glucose tolerance testing, total-body dual-energy x-ray absorptiometry, and SC abdominal fat biopsy. Adipose-IR (fasting insulin × total fatty acid levels) and SC abdominal ASC gene expression were compared between groups and correlated with clinical outcomes. Adipose-IR was greater in women with PCOS than in control subjects (P < 0.01), with 29 pmol/L × mmol/L providing 94% specificity and 80% sensitivity in discriminating the two groups (P < 0.001). Adipose-IR positively correlated with serum androgen and log of fasting triglyceride (TG) levels, percentage of small adipocytes (P < 0.01, all correlations), and acute insulin response to glucose (P < 0.05); and negatively correlated with insulin sensitivity (Si; P < 0.025) and serum adiponectin levels (P < 0.05). Adjusting for serum androgens, adipose-IR correlations with Si and log TG levels remained si

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
AdiponectinAdultFemaleGene Expression RegulationHumansInsulin ResistancePolycystic Ovary SyndromeSubcutaneous Fat, AbdominalTestosteroneTransforming Growth Factor beta

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research